Pasadena Private Wealth, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 127 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Pasadena Private Wealth, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2023$6,675
-3.0%
10,5960.0%0.00%0.0%
Q4 2022$6,878
-61.8%
10,5960.0%0.00%
-66.7%
Q3 2022$18,000
+38.5%
10,5960.0%0.01%
+50.0%
Q2 2022$13,000
+85.7%
10,5960.0%0.00%
+100.0%
Q1 2022$7,000
-41.7%
10,5960.0%0.00%
-50.0%
Q4 2021$12,000
-36.8%
10,5960.0%0.00%
-42.9%
Q3 2021$19,00010,5960.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$49,697,00012.67%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 9,642,760$31,628,0005.74%
MILLER VALUE PARTNERS, LLC 12,619,730$41,393,0001.84%
MAGNOLIA CAPITAL ADVISORS LLC 90,585$297,0000.38%
Sargent Investment Group, LLC 232,025$759,0000.28%
Old West Investment Management, LLC 210,583$690,0000.20%
Virtus ETF Advisers LLC 112,619$369,0000.18%
tru Independence LLC 213,712$701,0000.10%
AIGEN INVESTMENT MANAGEMENT, LP 180,297$591,0000.08%
Golden State Wealth Management, LLC 90,585$297,0000.08%
View complete list of ZIOPHARM ONCOLOGY INC shareholders